Rimonabant Acomplia

 Acomplia online

Sanofi-Aventis  said on Tuesday the European Commission had endorsed the positive opinion of the European Medicines Evaluation Agency (EMEA) for its anti-obesity drug Acomplia (rimonabant) to include type 2 diabetes trial results into the European label (section 5.1). The update is based on the results of the SERENADE study, which showed rimonabant 20 mg significantly improved glycemic control in newly diagnosed naive type 2 diabetic patients, the statement said.

The study also demonstrated that rimonabant 20mg had additional benefits on cardio-metabolic risk factors beyond diabetes.

Rimonabant Acomplia online works by blocking receptors of a substance called cannabinoid 1, which stimulates hunger and other cravings in the brain and is also present in fat tissue. This receptor is also present in the fat tissue and controls the hunger in the brain. So when you take this rimonabant drug, you will automatically eat less because you do not feel hunger. As a result you will take less food which helps you to reduce your cholesterol levels. When you start losing weight, the first place you will lose body fat is your mid-section. And your cholesterol will go down and your blood pressure will return to healthy levels.

Tipped as a future multibillion-dollar-a-year seller, Acomplia is all set to surprise the weight loss drug market. Acomplia has dual advantage attached to it property since it can help people both lose weight and quit smoking. That is really lot more than you can ever expect from even a miracle pill.

Acomplia pills are the newest entrant in the UK pharmaceutical market making waves for its dual nature of weight loss and smoking cessation property. As the wonder drug Accomplia online is finally approved for sale through prescription, we have got numerous queries on the online buying options related to this drug.